Cervical cancer is one of the leading life-threatening cancers around the globe. In fact, it is the fourth most common reported cancer in women with an estimate of 530,000 cases every year. In Saudi Arabia, a recent report from the Human papilloma virus (HPV) information centre has indicated annual cases of 358 diagnosed cervical cancer, placing it as the eighth most frequent cancer in the country. Such disease has been found to have a strong association with HPV infection as the primary risk factor. HPV is one of the most common sexually transmitted diseases (STDs) around the world, where certain oncogenic types of the infection can result in serious consequences in the female above 15 years of age, mainly cervical cancer. Nevertheless, there is an obvious limitation in data from Saudi Arabia regarding such infection and its complications. In Saudi Arabia, HPV vaccine has been available since 2010 for all women upon request or if prescribed by their physicians. However, despite its availability to public, statistics showed low rates of vaccine endorsement as well as Pap smear test among Saudi women. This study aimed to assess the knowledge gap and attitude of women in Makkah city towards HPV vaccine along with Pap smear screen test. Our results have shown a remarkable lack of awareness from the participants in regards to the HPV vaccine and Pap smear, although their awareness about the cervical cancer was high. The data also pointed out a possible malpractice of some physicians toward the recommendation of Pap smear test to their patients. In conclusion, there is still a clear gap in the knowledge and attitude from our participants towards the prevention measures of HPV infection and cervical cancer, which would possibly affect the roll out of HPV vaccine program. Therefore, more health promotion programs and campaign are needed to ensure success of the vaccine roll out and help avoid further complication of such disease
Coronavirus disease 2019 caused by the novel severe respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pandemic and potentially fatal disease. COVID-19 cases are on the rise globally; this also includes risk groups such as pregnant women and neonates. Herein, we report the first COVID-19 cesarean delivery case of an in vitro fertilization (IVF) pregnancy in a Saudi woman. A postdate pregnant healthy woman tested positive with COVID-19 on her 38 weeks + five days. On her 40 weeks + five days, the woman had dilation without contractions; thereby, cesarean delivery was decided. The delivery was successful, with no complications in the mother and neonate. The preferable outcomes of this case could be attributable to some factors: multidisciplinary medical management, the mother's young age, and COVID-19 infection during the late trimester.
Several cell types and a wide variety of inflammatory mediators are involved in the chronic airway inflammation that characterizes asthma. The study aims to uncover a link between high serum immunoglobulin E IgE levels and childhood asthma. This cross-sectional study was conducted from March to July 2022 at Khyber Teaching Hospital Peshawar, Pakistan. Asthma patients traveling to the clinic's out-of-the-way chest medication branch were given a clear explanation of the review's goal, its system, and its security measures. This study included 65 patients. This study lists demographic, clinical, and useful characteristics. The research review included 18-60-year-old patients. 40 (66.67%) of our 60 patients were men, and 20 (33.33%) were women. Out of 60 cases, 56.67% had severe asthma. The researchers concluded that the serum levels of immunoglobulin E in asthmatics were much higher than those in normal patients. The severity of the patient's asthma was correlated with an increase in their IgE levels, on average.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.